Evidence map›Paper›PMID 21037579›Full record

ArticleNature immunology2010

CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire.

Annemieke de Jong, Victor Peña-Cruz, Tan-Yun Cheng, Rachael A Clark, Ildiko Van Rhijn, D Branch Moody

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 1 synthesis or guideline pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. CD1a and Lipids as Mediators of T Cell Activation in the Skin.The Journal of investigative dermatology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. CD1a and skin T cells: a pathway for therapeutic intervention.Clinical and experimental dermatology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. CD1 displays its own negative regulators.Current opinion in immunology · 2023
    Review
  19. Article
  20. Group AScience immunology · 2023
    Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Annemieke de JongDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Victor Peña-Cruz
Tan-Yun Cheng
Rachael A Clark
Ildiko Van Rhijn
D Branch Moody
Brigham and Women's Hospital · USHarvard University · USDana-Farber Cancer Institute · USUtrecht University · NL

Funding

Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 2003 to 2023
$42.5M
TIM recognition of phosphatidylserine regulates innate and adaptive immunityP01AI054456 · NIAID · STANFORD UNIVERSITY · PI FREEMAN, GORDON JAMES · 2003 to 2014
$12.8M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
CD1 Presentation of Self Lipids to Human T CellsR01AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2002 to 2024
$9.4M
Remodeling of the M. tuberculosis cell wall during infectionR01AI071155 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2006 to 2010
$2.1M
Immune Evasion in Human Squamous Cell Carcinomas of the SkinR01AR056720 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2009 to 2013
$1.9M
CD1 autoreactive T cells in human inflammatory skin diseaseR37AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DAVID Branch MOODY · 2025 to 2026
$1.1M
NIAID NIH HHS AI054456NIAID NIH HHS AI056299NIAID NIH HHS AI071155NIAID NIH HHS P01 AI054456NIAID NIH HHS P01 AI056299NIAID NIH HHS R01 AI049313NIAMS NIH HHS AR 048632NIAMS NIH HHS AR056720NIAMS NIH HHS R01 AR048632NIAMS NIH HHS R01 AR056720NIAMS NIH HHS R37 AR048632
6 · The paper itself

Abstract

CD1 activates T cells, but the function and size of the possible human T cell repertoires that recognize each of the CD1 antigen-presenting molecules remain unknown. Using an experimental system that bypasses major histocompatibility complex (MHC) restriction and the requirement for defined antigens, we show that polyclonal T cells responded at higher rates to cells expressing CD1a than to those expressing CD1b, CD1c or CD1d. Unlike the repertoire of invariant natural killer T (NKT) cells, the CD1a-autoreactive repertoire contained diverse T cell antigen receptors (TCRs). Functionally, many CD1a-autoreactive T cells homed to skin, where they produced interleukin 22 (IL-22) in response to CD1a on Langerhans cells. The strong and frequent responses among genetically diverse donors define CD1a-autoreactive cells as a normal part of the human T cell repertoire and CD1a as a target of the T(H)22 subset of helper T cells.

Indexed as

Antigens, CD1AutoimmunityCell SeparationChemotaxis, LeukocyteEnzyme-Linked Immunospot AssayFlow CytometryHumansInterleukin-22InterleukinsLangerhans CellsLymphocyte ActivationReceptors, Antigen, T-Cell, alpha-betaReverse Transcriptase Polymerase Chain ReactionSkinT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsAntigens, CD1CD1a antigenInterleukin-22InterleukinsReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID21037579
PMCPMC3131223
OpenAlexW1536006864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.